Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teicoplanin for Clostridioides difficile-associated diarrhea and colitis
CTR20190702Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teicoplanin in Clostridioides difficile colitis (CDI), Clostridioides difficile-associated colitis (CDI), sponsored by Sanofi. Started Apr 2019; status: terminated.
02
Drugs
teicoplanin
03
Conditions
Clostridioides difficile colitis (CDI)Clostridioides difficile-associated colitis (CDI)
Beyond the preview
Go deeper on CTR20190702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190702.